4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000010
CEO bought 213,000 shares at an average $0.02 ($4,807)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
30 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-02-12 | Purchase : show line 1 in the form | +1,000 | $0.02 | $22 | 21,132,623 | D |
| 2019-02-12 | Purchase : show line 2 in the form | +5,000 | $0.02 | $111 | 21,137,623 | D |
| 2019-02-12 | Purchase : show line 3 in the form | +2,500 | $0.02 | $58 | 21,140,123 | D |
| 2019-02-12 | Purchase : show line 4 in the form | +2,500 | $0.02 | $58 | 21,142,623 | D |
| 2019-02-12 | Purchase : show line 5 in the form | +5,000 | $0.02 | $115 | 21,147,623 | D |
| 2019-02-12 | Purchase : show line 6 in the form | +10,000 | $0.02 | $229 | 21,157,623 | D |
| 2019-02-12 | Purchase : show line 7 in the form | +5,000 | $0.02 | $113 | 21,162,623 | D |
| 2019-02-12 | Purchase : show line 8 in the form | +5,000 | $0.02 | $114 | 21,167,623 | D |
| Open-market purchases · 213,000 sh · avg $0.02 · $4,807 | ||||||
Loading xslF345X03/primary_doc.xml…